Safety profile of HTX-019 administered as an intravenous push in cancer patients: a retrospective review.
Safety profile of HTX-019 administered as an intravenous push in cancer patients: a retrospective review. Expert Opin Drug Saf. 2020 Feb; 19(2):205-210.